Company
Avenzo
Developing Next-Generation Oncology Therapies to Transform Cancer Treatment
Also known as Avenzo Therapeutics, Avenzo Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- San Diego, CA, United States
- Legal name
- Avenzo Therapeutics, Inc.
- avenzotx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At Avenzo, we’re committed to helping the millions diagnosed with cancer each year, taking a leading approach to tackle the complexities of the disease.
Funding snapshot
- Total raised
- $433MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series B, $60M2025-09-22
Funding rounds
- Round, 2025
- $47.2M2025-08-22, SEC form D sold, 20 investors
- Series A
- 2024-11-18
- Round, 2024
- $150M2024-03-26, Company stated
- Round, 2022
- $386M2022-09-14, SEC form D sold, 22 investors
Loading relationship preview